Download PDF
Klin Monbl Augenheilkd 2018; 235(06): 671-677
DOI: 10.1055/s-0043-120096
Handlungspfade
Georg Thieme Verlag KG Stuttgart · New York

Akanthamöbenkeratitis – klinische Zeichen, Diagnose, Therapie

Nóra Szentmáry
,
Loay Daas
,
Lei Shi
,
Kornelia Lenke Laurik
,
Berthold Seitz
Further Information

Publication History

Publication Date:
20 November 2017 (online)

Also available at
    Permissions and Reprints

Gräulich-schmutzige Epithelveränderungen, Perineuritis, multifokale stromale Infiltrate und ein Ringinfiltrat sind typischerweise Schlagwörter für die Akanthamöbenkeratitis. In der Regel wird über ein Jahr hinweg eine Dreifachbehandlung aus Polyhexamid, Propamidinisoethionat, Neomycin empfohlen. Kryotherapie, Amnionmembrantransplantation, Riboflavin-UVA-Crosslinking und Keratoplastik sind die Alternativen bei Fällen, bei denen eine lokale Behandlung keine Besserung zur Folge hat.
 

  • Literatur

  • 1 Meltendorf C, Duncker G. Akanthamöben-Keratitis. Klin Monatsbl Augenheilkd 2011; 228: R29-R43
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Szentmáry N, Göbels S, Matoula P. et al. Die Akanthamöbenkeratitis – ein seltenes und oft spät diagnostiziertes Chamäleon. Klin Monatsbl Augenheilkd 2012; 229: 521-528
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009; 148: 487-499
    CrossrefPubMedGoogle Scholar
  • 4 Daas L, Viestenz A, Schnabel P. et al. Confocal microscopy in acanthamoeba keratitis as an early relapse-marker. Clin Anat 2017; DOI: 10.1002/ca.22925.
    PubMedGoogle Scholar
  • 5 Daas L, Szentmáry N, Eppig T. et al. Das Deutsche Akanthamöbenkeratitis-Register – Erste Ergebnisse einer multizentrischen Erhebung. Ophthalmologe 2015; 112: 752-763
    CrossrefPubMedGoogle Scholar
  • 6 Pfister DR, Cameron JD, Krachmer JH. et al. Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol 1996; 121: 119-128
    CrossrefPubMedGoogle Scholar
  • 7 Mathers WD, Sutphin JE, Folberg R. et al. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 1996; 121: 129-142
    CrossrefPubMedGoogle Scholar
  • 8 Aspöck H. Grundzüge der Diagnostik. In: Hiepe T, Lucius R, Gottstein B. Allgemeine Parasitologie mit den Grundzügen der Immunologie, Diagnostik und Bekämpfung. Stuttgart: Parey in MVS Medizinverlage; 2006: 339-457
    Google Scholar
  • 9 Sharma S, Athmanathan S, Atha-Ur-Rasheed M. et al. Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. Indian J Ophthalmol 2001; 49: 181-186
    PubMedGoogle Scholar
  • 10 Claerhout I, Goegebuer A, Van Den Broecke C. et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol 2004; 242: 648-653
    CrossrefPubMedGoogle Scholar
  • 11 Awwad ST, Petroll WM, McCulley JP. et al. Updates in Acanthamoeba keratitis. Eye Contact Lens 2007; 33: 1-8
    CrossrefPubMedGoogle Scholar
  • 12 Perry HD, Donnenfeld ED, Foulks GN. et al. Decreased corneal sensation as an initial feature of Acanthamoeba keratitis. Ophthalmology 1995; 102: 1565-1568
    CrossrefPubMedGoogle Scholar
  • 13 Patel DV, McGhee CN. Acanthamoeba keratitis: a comprehensive photographic reference of common and uncommon signs. Clin Experiment Ophthalmol 2009; 37: 232-238
    CrossrefPubMedGoogle Scholar
  • 14 Papathanassiou M, Gartry D. Sterile corneal ulcer with ring infiltrate and hypopyon after recurrent erosions. Eye 2007; 21: 124-126
    CrossrefPubMedGoogle Scholar
  • 15 Thomas KE, Purcell TL, Tanzer DJ. et al. Delayed diagnosis of microsprodial stromal keratitis: unusual Wessely ring presentation and partial treatment with medications against Acanthamoeba. BMJ Case Rep 2011; DOI: 10.1136/bcr.08.2010.3233.
    PubMedGoogle Scholar
  • 16 Kremer I, Cohen EJ, Eagle jr. RC. et al. Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 1994; 20: 45-48
    PubMedGoogle Scholar
  • 17 Clarke DW, Alizadeh H, Niederkorn JY. Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci 2005; 46: 2472-2478
    CrossrefPubMedGoogle Scholar
  • 18 Shigeyasu C, Shimazaki J. Ocular surface reconstruction after exposure to high concentrations of antiseptic solutions. Cornea 2012; 31: 59-65
    CrossrefPubMedGoogle Scholar
  • 19 Awwad ST, Heilman M, Hogan RN. et al. Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome. Ophthalmology 2007; 114: 313-320
    CrossrefPubMedGoogle Scholar
  • 20 Herz NL, Matoba AY, Wilhelmus KR. Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology 2008; 115: 866-869
    CrossrefPubMedGoogle Scholar
  • 21 Kelley PS, Dossey AP, Patel D. et al. Secondary glaucoma associated with advanced acanthamoeba keratitis. Eye Contact Lens 2006; 32: 178-182
    CrossrefPubMedGoogle Scholar
  • 22 Ehlers N, Hjordtal J. Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis?. Acta Ophthalmol Scand 2004; 82: 228-231
    CrossrefPubMedGoogle Scholar
  • 23 Iovieno A, Gore DM, Carnt N. et al. Acanthamoeba sclerokeratitis: epidemiology, clinical features and treatment outcomes. Ophthalmology 2014; 121: 2340-2347
    CrossrefPubMedGoogle Scholar
  • 24 Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99: 185-191
    CrossrefPubMedGoogle Scholar
  • 25 Ficker L, Seal D, Warhurst D. et al. Acanthamoeba keratitis – resistance to medical therapy. Eye (Lond) 1990; 4 (Pt 6): 835-838
    CrossrefPubMedGoogle Scholar
  • 26 Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985; 69: 778-782
    CrossrefPubMedGoogle Scholar
  • 27 Elder MJ, Kilvington S, Dart JK. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994; 35: 1059-1064
    PubMedGoogle Scholar
  • 28 Sunada A, Kimura K, Nishi K. et al. In vitro evaluations of topical agents to treat acanthamoeba keratitis. Ophthalmology 2014; 121: 2059-2065
    CrossrefPubMedGoogle Scholar
  • 29 Polat ZA, Walochnik J, Obwaller A. et al. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis. Clin Exp Ophthalmol 2014; 42: 151-158
    CrossrefPubMedGoogle Scholar
  • 30 McClellan K, Howard K, Niederkorn JY. et al. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 2001; 42: 2885-2893
    PubMedGoogle Scholar
  • 31 Carnt N, Optom B, Robaei D. et al. The impact of topical corticosteroids used in conjunction with antiamoebic therapy on the outcome of acanthamoeba keratitis. Ophthalmology 2016; 123: 984-990
    CrossrefPubMedGoogle Scholar
  • 32 DʼAversa G, Stern GA, Driebe jr. WT. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 1995; 113: 1120-1123
    CrossrefPubMedGoogle Scholar
  • 33 Amoils SP, Heney C. Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am J Ophthalmol 1999; 127: 718-720
    CrossrefPubMedGoogle Scholar
  • 34 Oldenburg CE, Acharya NR, Tu EZ. et al. Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea 2011; 30: 1363-1368
    CrossrefPubMedGoogle Scholar
  • 35 Sunada A, Kimura K, Nishi K. et al. In vitro evaluations of topical agents to treat acanthamoeba keratitis. Ophthalmology 2014; 121: 2059-2065
    CrossrefPubMedGoogle Scholar
  • 36 Brooks Jr JG, Coster DJ, Badenoch PR. Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea 1994; 13: 186-189
    CrossrefPubMedGoogle Scholar
  • 37 Klüppel M, Reinhard T, Sundmacher R. et al. Therapie der fortgeschrittenen Amöbenkeratitis mit Keratoplastik à chaud und adjuvanter Kryoapplikation. Ophthalmologe 1997; 94: 99-103
    CrossrefPubMedGoogle Scholar
  • 38 Seitz B, Resch MD, Schlötzer-Schrehardt U. et al. Histopathology and ultrastructure of human corneas after amniotic membrane transplantation. Arch Ophthalmol 2006; 124: 1487-1490
    CrossrefPubMedGoogle Scholar
  • 39 Szentmáry N, Goebels S, Bischoff M. et al. Photodynamische Therapie (PDT) bei infektiöser Keratitis. Ophthalmologe 2012; 109: 165-170
    CrossrefPubMedGoogle Scholar
  • 40 Khan YA, Kashiwabuchi RT, Martins SA. et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeben keratitis: report of 3 cases. Ophthalmology 2011; 118: 324-331
    CrossrefPubMedGoogle Scholar
  • 41 Laurik KL, Szentmáry N, Daas L. et al. Penetrating keratoplasty à chaud in acute acanthamoeba keratitis. ARVO Abstract 2016.
    PubMedGoogle Scholar
  • 42 Hager T, Hasenfus A, Stachon T. et al. Crosslinking and corneal cryotherapy in acanthamoeba keratitis – a histological study. Graefes Arch Clin Exp Ophthalmol 2016; 254: 149-153
    CrossrefPubMedGoogle Scholar
  • 43 Seitz B, Langenbucher A, Kus MM. et al. Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty. Ophthalmology 1999; 106: 1556-1564
    PubMedGoogle Scholar
  • 44 Szentmáry N, Langenbucher A, Kus MM. et al. Elliptical nonmechanical corneal trephination – Intraoperative complications and long-term outcome of 42 consecutive penetrating keratoplasties. Cornea 2007; 26: 414-420
    CrossrefPubMedGoogle Scholar
  • 45 Robaei D, Carnt N, Minassian DC. et al. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology 2015; 122: 17-24
    CrossrefPubMedGoogle Scholar
  • 46 Szentmáry N, Daas L, Matoula P. et al. Akanthamöbenkeratitis. Ophthalmologe 2013; 110: 1203-1210
    CrossrefPubMedGoogle Scholar